Ajooni Biotech Ltd - Stock Valuation and Financial Performance

BSE: 0 | NSE: AJOONI | Animal Feed | Small Cap

BSE Share Price
Not Listed

DeciZen - make an informed investing decision on Ajooni Biotech

Overall Rating
M-Cap below 500cr. High Risk from low Liquidity Bole Toh

1. Quality

2. Valuation

Undervalued

3. Price Trend

Ajooni Biotech stock performance -

mw4me loader
P/E Ratio (SA):
50.39
Market Cap:
122.8 Cr.
52-wk low:
0
52-wk high:
0

Is Ajooni Biotech Ltd an attractive stock to invest in?

1. Is Ajooni Biotech Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Ajooni Biotech Ltd is a below average quality company.

2. Is Ajooni Biotech Ltd undervalued or overvalued?

The key valuation ratios of Ajooni Biotech Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

3. Is Ajooni Biotech Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Ajooni Biotech Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Ajooni Biotech:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Ajooni Biotech Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24TTM
ROCE % 27.6%18.6%36.2%10%3.8%4.4%5.1%9.1%6%7.8%-
Value Creation
Index
1.00.31.6-0.3-0.7-0.7-0.6-0.4-0.6-0.5-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 7.213.228.542.439.740517474.580.191
Sales YoY Gr.-83.5%115.7%48.5%-6.3%0.8%27.5%45.1%0.6%7.5%-
Adj EPS 0.20.30.50.10.10.10.10.20.10.10.1
YoY Gr.-35%100%-77.8%-41.7%0%0%200%-38.1%7.7%-
BVPS (₹) 1.21.51.93.23.43.33.13.34.84.95
Adj Net
Profit
0.10.10.30.40.20.30.41.11.11.22
Cash Flow from Ops. 0.2-0.600-4.9-4.41.23.7-5.6-4-
Debt/CF from Ops. 0-1.300-1-1.25.91.5-0.9-0.6-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 30.7%15.1%16.2%7.5%
Adj EPS -3.9%14.9%26%7.7%
BVPS17.1%7.3%16.3%2.3%
Share Price - -2.3% -50.3% 10.5%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24TTM
Return on
Equity %
18.720.436.66.31.92.32.46.63.92.92.8
Op. Profit
Mgn %
1.81.72.32.21.83.13.24.23.72.82.9
Net Profit
Mgn %
10.710.90.60.80.71.41.51.52.7
Debt to
Equity
01.50.60.50.40.30.40.30.10.10
Working Cap
Days
4346515385135138106171185216
Cash Conv.
Cycle
51221758103986473100189

Recent Performance Summary

Sales growth is growing at healthy rate in last 3 years 16.21%

Net Profit is growing at healthy rate in last 3 years 25.99%

Sales growth is good in last 4 quarters at 22.58%

Return on Equity has declined versus last 3 years average to 2.80%

Latest Financials - Ajooni Biotech Ltd.

Standalone Consolidated
TTM EPS (₹) 0.1 -
TTM Sales (₹ Cr.) 91 -
BVPS (₹.) 5 -
Reserves (₹ Cr.) 52 -
P/BV 1.43 -
PE 50.39 -
From the Market
52 Week Low / High (₹) 0.00 / 0.00
All Time Low / High (₹) - / -
Market Cap (₹ Cr.) 123
Equity (₹ Cr.) 34.5
Face Value (₹) 2
Industry PE 34.7

Management X-Ray of Ajooni Biotech:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Ajooni Biotech

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Sales7132942404051747480
Operating Expenses 7132841393949717278
Manufacturing Costs0001111111
Material Costs6112438363543646670
Employee Cost 0011111122
Other Costs 1132124434
Operating Profit 0011112332
Operating Profit Margin (%) 1.8%1.7%2.3%2.2%1.8%3.0%3.2%4.2%3.7%2.8%
Other Income 0000000002
Interest 0000001101
Depreciation 0000001111
Exceptional Items 0000000000
Profit Before Tax 0000001123
Tax 0000000001
Profit After Tax 0000000112
PAT Margin (%) 1.0%0.7%1.0%0.9%1.0%0.9%0.7%1.4%1.5%2.7%
Adjusted EPS (₹)0.20.30.60.10.10.10.10.20.10.3
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24

Equity and Liabilities

Shareholders Fund 01111121616164243
Share Capital 00066810101818
Reserves 001567662425
Minority Interest0000000000
Debt0115556452
Long Term Debt0010412322
Short Term Debt0104144230
Trade Payables11511257102
Others Liabilities 0063001121
Total Liabilities 221319182328295847

Fixed Assets

Gross Block001223591015
Accumulated Depreciation0001112345
Net Fixed Assets00111246610
CWIP 0000002001
Investments 0066431142
Inventories00425356715
Trade Receivables111351314142113
Cash Equivalents 0005100000
Others Assets00023222205
Total Assets 221319182328295847

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Cash Flow From Operating Activity 0-100-5-414-6-4
PBT 0000001123
Adjustment 0000011211
Changes in Working Capital 0-100-6-5-01-8-7
Tax Paid 000000000-1
Cash Flow From Investing Activity 000010-3-2-168
Capex 000020-4-2-3-6
Net Investments 0000-1000-1313
Others 0000000001
Cash Flow From Financing Activity 0100-132-222-4
Net Proceeds from Shares 00001310220
Net Proceeds from Borrowing 00002-311-10
Interest Paid 000000-1-10-1
Dividend Paid 0000000000
Others 0100-431-21-3
Net Cash Flow 0000-5-10000
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Ratios
ROE (%)N/A20.3836.986.83.722.542.46.583.875.12
ROCE (%)N/A18.6236.1910.033.844.355.079.095.997.75
Asset Turnover Ratio6.836.563.742.642.121.952.012.611.711.52
PAT to CFO Conversion(x)N/AN/AN/AN/AN/AN/AN/A4-6-2
Working Capital Days
Receivable Days22281618358094688476
Inventory Days13113027323831283251
Payable Days37314530101631354730

Ajooni Biotech Ltd Stock News

Ajooni Biotech Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Ajooni Biotech on 01-Jan-1970 05:30 is ₹0.00.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 01-Jan-1970 05:30 the market cap of Ajooni Biotech stood at ₹122.8.
The latest P/E ratio of Ajooni Biotech as of 01-Jan-1970 05:30 is 50.39.
The latest P/B ratio of Ajooni Biotech as of 01-Jan-1970 05:30 is 1.43.
The 52-week high of Ajooni Biotech is ₹0.00 and the 52-week low is ₹0.00.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Ajooni Biotech is ₹91.02 ( Cr.) .

About Ajooni Biotech Ltd

No data to display
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.